Eastern Cooperative Oncology Group (ECOG) performance status =<  (Karnofsky >= %) and life expectancy greater than  months; furthermore, enrollment of patients with greater than  measurable lesions is discouraged
Eastern Cooperative Oncology Group (ECOG) performance status ?  and minimum life expectancy of  weeks
Patients must have Eastern Cooperative Oncology Group (ECOG) performance status =<  and a life expectancy of at least  months
Patients must have Eastern Cooperative Oncology Group (ECOG) performance status -\r\n* NOTE: Participants with impaired decision-making capacity (IDMC) should not be allowed to participate in this study due to its complexity
Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status =< 
Eastern Cooperative Oncology Group (ECOG) performance status of zero to two unless decline is due to bony disease
ELIGIBILITY CRITERIA - PHASE I (ARMS A, B, C): Eastern Cooperative Oncology Group (ECOG) performance status -
Patients must be ambulatory with good performance status (Eastern Cooperative Oncology Group [ECOG]  or )
INCLUSION CRITERIA FOR SECOND-LINE THERAPY: Eastern Cooperative Oncology Group (ECOG) performance status  or 
SAFETY RUN-IN: Eastern Cooperative Oncology Group (ECOG) performance status -
Eastern Cooperative Oncology Group (ECOG) performance status of  to  and Life expectancy of at least  weeks
Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status of -
Performance status of Eastern Cooperative Oncology Group (ECOG) -; patients with ECOG of  may be allowed to enroll after discussion with the regulatory-sponsor/principal investigator and medical monitor, and if the performance status is believed to be secondary to lymphoma related symptoms and performance status is expected to improve once chemotherapy commences
Patients must exhibit a/an Eastern Cooperative Oncology Group (ECOG) performance status of -
ENROLLMENT TO THE DOSE ESCALATION, EXPANSION AND PART II: Eastern Cooperative Oncology Group (ECOG) performance status =< 
Must have Eastern Cooperative Oncology Group (ECOG) Performance Status of  or , assessed within  days prior to randomization. Two observers qualified to perform assessment of the performance status will be required to perform this assessment. If discrepant, the one with the most deteriorated performance status will be considered true.
Eastern Cooperate Oncology Group (ECOG) performance status =< 
Eastern Collaborative Oncology Group (ECOG) performance status of  or  at screening
Eastern Cooperative Oncology Group (ECOG) performance status of ? , measured within  hours before the start of treatment.
Eastern Collaborative Oncology Group (ECOG) Performance Status of ?
Eastern Cooperative Oncology Group (ECOG) performance status of - with no clinical deterioration over the previous  weeks and likely able to complete at least  weeks of treatment.
European Cooperative Oncology Group (ECOG) performance status  or .
Eastern Cooperative Oncology Group Performance Status (ECOG PS) of  or . . Subjects must have adequate hematopoietic, liver, renal and coagulation function as assessed by specific laboratory criteria.
Performance status: Eastern Cooperative Oncology Group (ECOG) - and life expectancy >=  year
Eastern Cooperative Oncology Group (ECOG) performance status of  or  and minimum life expectancy of ?  months
Eastern Cooperative Oncology Group (ECOG) performance status =<  (Karnofsky >= %) is required for eligibility; those patients with lower performance status based solely on bone pain secondary to multiple myeloma are eligible
Eastern Cooperative Oncology Group (ECOG) performance status =< ; performance status of  will be accepted if impairment is caused by DLBCL complications and improvement is expected once therapy is initiated
Eastern Cooperative Oncology Group (ECOG) performance status =<  (Phase I), =<  (Phase II)
Eastern cooperative oncology group (ECOG) performance status ?  and life expectancy >  weeks
Clinical performance status of Eastern Cooperative Oncology Group (ECOG)  or  at enrollment and within  days of initiating lymphodepleting chemotherapy.
Eastern Cooperative Oncology Group performance status - at time of informed consent
Eastern Cooperative Oncology Group (ECOG) performance status of  or , and estimated life expectancy of ?  months
COHORT : HORMONE RECEPTOR POSITIVE BREAST CANCER: Eastern Cooperative Oncology Group (ECOG) performance status  or 
Patients must be medically fit to undergo surgery as determined by the treating medical and surgical oncology team and have Eastern Cooperative Oncology Group (ECOG) performance status -.
An eastern cooperative oncology group performance status (ECOG PS) of  to  at screening and adequate hematological, renal and hepatic function as defined by protocol specified criteria.
Has Eastern Cooperative Oncology Group (ECOG) performance status of  or , with no deterioration over the previous  weeks.
Eastern Cooperative Oncology Group (ECOG) performance status of -, however grade  patients may be enrolled at the discretion of the treating radiation oncologist
Eastern Cooperative Oncology Group (ECOG) performance status =<  for patients treated in the expansion phase; ECOG performance status (PS) =<  is required for participants in the dose-finding portion of the study
Eastern Cooperative Oncology Group (ECOG) performance status of -; able to understand and sign the Informed Consent document
Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) status of -\r\n* NOTE: ECOG performance status  will be allowed only if thought to be directly secondary to adenoid cystic carcinoma disease by treating physician
Eastern Cooperative Oncology Group (ECOG) performance status =<  (There may be certain patients with performance status [PS]  in the context of rapidly proliferative/refractory ALL who would benefit from this regimen. We dont want to exclude such patients who may derive benefit from this salvage regimen)
Eastern Co-operative Oncology Group (ECOG) performance status < or = .
Eastern Cooperative Oncology Group (ECOG) performance status =<  for MSS participants or <  for microsatellite instability (MSI) participants
Has an Eastern Cooperative Oncology Group (ECOG) performance status of  or  at initial screening and at baseline.
Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status of =< 
Eastern Cooperative Oncology Group (ECOG) performance status  to ; (performance status of  will be allowed if poor performance status is thought to be directly secondary to ALL)
Eastern Cooperative Oncology Group (ECOG) performance status  or  with no deterioration over the previous  weeks and an estimated life expectancy of greater than  weeks
Eastern Cooperative Oncology Group (ECOG) performance status of  or ; patients with an ECOG performance status of  will be allowed at the discretion of the treating investigator in agreement with the sponsor-investigator
Participant has an Eastern Cooperative Oncology Group (ECOG) Performance Status of  to  for Monotherapy and  to  for Combination.
Eastern Cooperative Oncology Group (ECOG) performance status of =<  or greater, based on treating physicians discretion
European Cooperative Oncology Group (ECOG) performance status  or 
Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) status of -; ECOG performance status  and  will be allowed only if decline in performance status is thought to be directly secondary to breast cancer disease burden by treating physician
Eastern Cooperative Oncology Group (ECOG) performance status =<  or expected survival duration of >  months
Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status of , , or 
Eastern Cooperative Oncology Group (ECOG) performance status of =<  and fit for induction therapy in the opinion of the treating physician
History/physical examination, including breast exam and documentation of weight and Eastern Cooperative Oncology Group (ECOG) performance status
Adult patients with an Eastern Cooperative Oncology Group (ECOG) performance status - and a life expectancy of  months or more
The subject must have a performance status of - as determined by criteria set forward by the Eastern Cooperative Oncology Group
Eastern Co-operative Oncology Group (ECOG) performance status of ? .
CAPMATINIB INCLUSION CRITERIA: Eastern Cooperative Oncology Group (ECOG) performance status -
Eastern Cooperative Oncology Group (ECOG) performance status and/or other performance status , , or ; performance status of  permissible if related to disease
Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status of =< 
Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status of -
Eastern Cooperative Oncology Group performance status must be  or , and life expectancy should be approximately  months or more.
Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status of -
PHASE I STUDY ELIGIBILITY CRITERIA:\r\nEastern Cooperative Oncology Group (ECOG) performance status =< 
Southwest Oncology Group (SWOG) performance status >= .
Patients with Eastern Cooperative Oncology Group (ECOG) performance status worse than  (ie unable to perform their own activities of daily living [ADLs] without assistance, unable to spend less than % of day out of bed)
Eastern Cooperative Oncology Group (ECOG) performance status of zero, one, or two
Eastern Cooperative Oncology Group (ECOG) performance status  ( if it is directly disease related and is expected to get better if the acute lymphoblastic leukemia/lymphoma [ALL] is under control)
Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of  or  (performance status of  will be allowed if poor performance status is thought to be directly secondary to patients Hodgkin lymphoma [HL])
Adequate performance status (Eastern Cooperative Oncology Group [ECOG] < ) and research participant does not require mechanical ventilation
Eastern Clinical Oncology Group performance status  or 
Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status of  or 
Eastern Clinical Oncology Group performance status  or 
Eastern Cooperative Oncology Group (ECOG)-American College of Radiology Imaging Network (ACRIN) performance status between -
Relapsed/refractory MCL: Eastern Cooperative Oncology Group (ECOG) performance status of  or less
Newly diagnosed MCL: Eastern Cooperative Oncology Group (ECOG) performance status of  or less
Patient eligible for standard induction chemotherapy based on Eastern Cooperative Oncology Group (ECOG) performance status (PS) and vital organ function at the discretion of the treating physician
Subjects must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status of  or 
Eastern Cooperative Oncology Group (ECOG) performance status =<  and life expectancy greater than  weeks based on the investigator's clinical judgment
Participants will not be excluded based on performance status; for patients with Eastern Cooperative Oncology Group (ECOG) performance status >= to  the dosing schedule will be discussed with study chairman
Patients >  may be considered if performance status > % or Eastern Cooperative Oncology Group (ECOG) =<  and comorbidity score < ; these patients must be discussed with the principal investigator (PI), Rachel Salit prior to enrollment
Clinical performance status of Eastern Cooperative Oncology Group (ECOG) - (Turnstile I)
Eastern cooperative oncology group (ECOG) performance status of - with a life expectancy ?  months
Easter Cooperative Oncology Group (ECOG) Performance Status ? 
Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status of =< 
ORAL CAVITY SQUAMOUS CELL CARCINOMA COHORT: Eastern Cooperative Oncology Group (ECOG) performance status < 
Eastern Cooperative Oncology Group (ECOG) performance status of , , or , and estimated survival of at least  months
Eastern Cooperative Oncology Group (ECOG) performance status of =<  and fit for induction therapy in the opinion of the treating physician
Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status -
Patients must have Eastern Cooperative Oncology Group (ECOG) performance status - and expected survival >  months from study enrollment
Eastern Cooperative Oncology Group (ECOG) performance status being - within  week of planned start of therapy
FOR TISSUE COLLECTION TO ESTABLISH PDX (PART ): Eastern Cooperative Oncology Group (ECOG) performance status of -.
Southwest Oncology Group (SWOG) performance status -
Eastern Cooperative Oncology Group (ECOG) performance status -, life expectancy >  months
Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status of =< 
The subject must have a performance status of - as determined by criteria set forward by the Eastern Cooperative Oncology Group
DOSE ESCALATION COHORT: Eastern Cooperative Oncology Group (ECOG) performance status -
Eastern Cooperative Oncology Group (ECOG) performance status =<  (Karnofsky >= %)\r\n* Exception will be made for patients with ECOG performance status =<  and Karnofsky performance scale >= %, who require the use of wheelchairs, walkers or canes as well as assistance with daily routines secondary to disabilities caused by ECD cerebellar or brain disease that has been stable for >=  months
PSTAT SCREENING: Eastern Cooperative Oncology Group (ECOG) performance status -
Patients must have Eastern Cooperative Oncology Group (ECOG) performance status of - with greater than six week life expectancy
Have an Eastern Cooperative Oncology Group (ECOG) performance status of =<  (Karnofsky >= %) and a life expectancy of at least  months; evaluation of ECOG is to be performed within  days prior to the date of allocation/randomization
Easter Cooperative Oncology Group (ECOG) performance status -
Eastern Cooperative Oncology Group (ECOG) performance status of  or  at initial enrollment, as assessed by clinician or investigator
Life expectancy of >=  months, Eastern Cooperative Oncology Group (ECOG) performance status =< 
Clinical performance status of Eastern Cooperative Oncology Group (ECOG)  - ; ECOG performance status of - will be inferred if the patients level of energy is >= % of baseline
Southwest Oncology Group (SWOG) performance status >= .
Clinical performance status of Eastern Cooperative Oncology Group (ECOG)  - ; ECOG performance status of - will be inferred if the patient's level of energy is >= % of baseline
Performance Status: Eastern Cooperative Oncology Group (ECOG) - unless mobility is limited from chronic physical handicap
Eastern Cooperation Oncology Group (ECOG) performance status -
Patients must have Eastern Cooperative Oncology Group (ECOG)-American College of Radiology Imaging Network (ACRIN) performance status of -
Southwest Oncology Group (SWOG) performance status >= .
Eastern Cooperative Oncology Group (ECOG) performance status of -; patients with ECOG performance status of  will be eligible if the lower performance status is deemed by the investigator to be due entirely to accelerated or blastic phase MPN and not due to another comorbidity
Patients who have received one prior regimen must have an Eastern Cooperative Oncology Group (ECOG) performance status of , , or ; patients who have received two or three prior regimens must have an ECOG performance status of  or 
South Western Oncology Group (SWOG) performance status -
AMKL PATIENTS: Patients must have an Eastern Cooperative Oncology Group (ECOG) status -
Eastern Cooperative Oncology Group performance status superior to .
Performance status with Eastern Cooperative Oncology Group (ECOG) score =< ; patients with performance status of  may be considered as long as the decline has been of short duration (<  month), and is due to their malignancy and not a comorbid condition (example: pain limiting activity)
ECOG (Eastern Cooperative Oncology Group) Performance Status of - within  days prior to registration. ECOG Performance Status of  will only be allowed if judged by the treating investigator as attributable exclusively to bone pain.
Eastern Cooperative Oncology Group (ECOG) performance status =< ; ECOG  indicates that the patient is fully active and able to carry on all pre-disease activities without restriction; and, ECOG  indicates that the patient is restricted in physically strenuous activity but is ambulatory and able to carry out work of a light or sedentary nature
Eastern Cooperative Oncology Group performance status of  to. For LM patients,  to  is acceptable.
Southwestern Oncology Group (SWOG) performance status >= .
Eastern Co-Operative Group (ECOG) performance status =  - 
Easter Cooperative Oncology Group (ECOG) performance status  or 
Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status of =< 
Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status of -
Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status of -
Eastern Cooperative Oncology Group (ECOG) performance of - with anticipated life expectancy of >=  weeks
Eastern Cooperative Oncology Group (ECOG) performance status of ,  or  as long as patients are eligible to receive chemotherapy along with concurrent radiotherapy
Eastern Cooperative Oncology Group (ECOG) performance status of -. Patients with performance status  are only eligible if the decline in performance status is due to metastatic prostate cancer.
Eastern Cooperative Oncology Group performance status - at time of informed consent
Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status: ECOG of  or  including patients who are not surgical candidates due to comorbid conditions
Must have a radiographically or clinically evaluable solid tumor Eastern Cooperative Oncology Group (ECOG) performance status of  or .
Eastern Cooperative Oncology Group (ECOG) performance status  or  ( is allowed only if due to bone pain)
Men and women ?  years of age with an Eastern Cooperative Oncology Group (ECOG) performance status ? 
Subjects must have Eastern Cooperative Oncology Group (ECOG) performance status of , , or ; if ECOG , they must also have a Charlson comorbidity index of =< 
Eastern Cooperative Oncology Group (ECOG) performance status  to  with no deterioration over the previous  weeks.
A life expectancy of at least  months and Eastern Cooperative Oncology Group (ECOG) performance status =< 
Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status of -
Patients must have Eastern Cooperative Oncology Group (ECOG) performance status of -, and life expectancy >=  years
Eastern Cooperative Oncology Group (ECOG) performance status of  to  at the trial entry and an estimated life expectancy of at least  months
Participants must have a performance status of - based on Eastern Cooperative Oncology Group (ECOG) criteria; participants with a poor performance status (-) based solely on bone pain will be eligible, provided there is documentation to verify this
Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status of , , or 
Eastern Cooperative Oncology Group (ECOG) performance status  -  and life expectancy >  weeks
Eastern Cooperative Oncology Group (ECOG) performance status =< ; patients with ECOG performance status of  (defined as being capable of only limited self-care, confined to bed or chair more than % of waking hours) will also be eligible only if the lower performance status is judged to be directly related to steroid and/or cGVHD effects
Eastern Cooperative Oncology Group (ECOG) performance status =<  for ages >=  or Lansky play >= % for ages =< 
Easter Cooperative Oncology Group (ECOG) Performance Status of -
Southwest Oncology Group (SWOG) performance status  or 
Eastern Cooperative Oncology Group (ECOG) performance status of =<  or greater, based on treating physician's discretion
Eastern Cooperative Oncology Group (ECOG) score - (Physically able to carry out light housework or office work through to being fully active as you were before cancer)
Patients must have Eastern Cooperative Oncology Group (ECOG) performance status of - with a greater than nine week life expectancy
Easter Cooperative Oncology Group (ECOG) performance status of ,,or 
Must have an Eastern Cooperative Oncology Group (ECOG) performance status of  or , adequate organ function, and a life expectancy of ?  months
Life expectancy - =/>  months, Eastern Cooperative Oncology Group status =  or .
Eastern Cooperative Oncology Group (ECOG) performance status of - and a life expectancy >  weeks.
Southwestern Oncology Group (SWOG) performance status  or 
Eastern Cooperative Oncology Group (ECOG) performance status  or  if age less than (<)  years; ECOG status of  if age  to  years
Subject can move around on their own, has an Eastern Cooperative Oncology Group (ECOG) performance status of  or , and has an estimated life expectancy of at least  months
ECOG PS (Eastern Cooperative Group Performance Status) of  or . . Ability to swallow oral capsules without difficulty. . Pregnancy Prevention Risk Management Plan:
Eastern Cooperative Oncology Group (ECOG) performance status of  or  in Parts  and  dose escalation and titration, and , ,  in Part  dose expansion
Eastern Cooperative Oncology Group (ECOG) performance status -; life expectancy at least  months
Male or female of >= years of age with the Eastern Cooperative Oncology Group (ECOG) performance status -, Child-Pugh score of -, and Life expectancy of  months or greater.
European Cooperative Oncology Group (ECOG) performance status of ? 
Performance status of - based on the Eastern Cooperative Oncology Group (ECOG) criteria; patients with performance status  or , based solely on bone pain, are also eligible, provided that there is a source document to verify this
Patient has received a platinum containing regimen. Eastern Cooperative Oncology Group (ECOG) performance status -. Radiographically-documented measureable disease.
Eastern Cooperative Oncology Group (ECOG) performance status:  or . NOTE: Subjects with a performance status of  can be enrolled if the subject's confinement to bed and inability to carry out work activities is due solely to cancer-related pain, as assessed by the Investigator.
Willingness to provide consent for biopsies positive or BRAF WT measurable disease, Eastern Cooperative Oncology Group (ECOG) performance status of  or , and adequate organ and marrow function
Eastern Co-operative Oncology Group (ECOG) performance status of -
Eastern Cooperative Oncology Group status of  or lower
Eastern Cooperative Oncology Group (ECOG) performance status  to  in Part  and Part , participants enrolled in the extension/tail portion, Part  and Part  must have an ECOG performance status of  or 
Patients with a Karnofsky Performance Status of % to % (or equivalent, Eastern Cooperative Oncology Group [ECOG] performance status of  or ); Performance Status Evaluation), and an anticipated life expectancy of ?  months.
Inclusion Criteria:\n\n          -  Life expectancy of at least  months\n\n          -  Histological or cytological documentation of advanced solid tumors\n\n          -  ECOG Performance Status of ?  (ECOG: Eastern Cooperative Oncology Group)\n\n          -  Adequate bone marrow, liver and renal function\n\n          -  Women of childbearing potential and men must agree to use adequate contraception
Eastern Cooperative Oncology Group (ECOG) performance status =<  for run-in phase; ECOG =<  for randomized phase
History/physical examination, including weight and assessment of Eastern Cooperative Oncology Group (ECOG) performance status, within  month of registration
Patients must have Eastern Cooperative Oncology Group (ECOG) performance status of - with greater than  months life expectancy
Performance status of Eastern Cooperative Oncology Group (ECOG) =<  or Karnofsky >= %; note: participants with lower performance status based solely on bone pain secondary to multiple myeloma will be eligible
A life expectance of at least  months as evidenced by Eastern Cooperative Oncology Group (ECOG) performance status -
Eastern Cooperative Oncology Group (ECOG) performance status of =< ; NOTE: For the phase I part of the study, patients with ECOG performance status  will be excluded
Eastern Cooperative Oncology Group Performance Status of  or  for Parts A and B. Subjects with Eastern Cooperative Oncology Group Performance Status of  or less may be entered into Part C with approval of medical monitor.
Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status of =< 
Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status of =< 
Eastern Cooperative Oncology Group (ECOG) performance status ? . Patients with stable ECOG scores of  may be allowed with medical monitor approval.
Patients with performance status of =<  (Eastern Cooperative Oncology Group performance status scale,  only allowed if decline in status is deemed related to lymphoma and felt potentially reversible by the treating physician)
Eastern Cooperative Oncology Group (ECOG) Performance status assessed between  and ; performance status of  will be accepted if impairment is caused by DLBCL complications and improvement is expected once therapy is initiated
PATIENT: Eastern Cooperative Oncology Group (ECOG) performance status from  (asymptomatic) to  (symptomatic and in bed > % of the day)
Eastern Cooperative Oncology Group (ECOG) performance status from  (asymptomatic) to  (symptomatic and in bed < % of day)
Patient is spending more than % of time out of bed on a daily basis, as measured by an Eastern Cooperative Oncology Group (ECOG) performance status rating of level , , or 
Eastern Cooperative Oncology Group (ECOG) performance status - during dose finding, - during MTD expansion
Eastern Cooperative Oncology Group (ECOG) performance status from  (asymptomatic) to  (symptomatic and in bed < % of the day)
Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status of  to .
At the time of recruitment, a life expectancy of greater than  months and/or a Karnofsky performance status of  or above or an Eastern Cooperative Oncology Group (ECOG) score of  or 
Eastern Cooperative Oncology Group (ECOG) performance status ,  or  at time of initial screening
There will be no discrimination based on gender, race, creed, or ethnic background; Eastern Cooperative Oncology Group (ECOG)/Karnofsky performance scale (KPS) will not be employed
Eastern Cooperative Oncology Group (ECOG) performance status of - (=participant has either normal activity, = participant has some symptoms but is nearly full ambulatory)
Eastern Cooperative Oncology Group (ECOG) rating of >=  or Karnofsky performance status (KPS) <  as rated by the oncology provider
Eastern Cooperative Oncology Group (ECOG) performance status from  (asymptomatic) to  (symptomatic and in bed < % of the day)
PATIENT: Eastern Cooperative Oncology Group (ECOG) performance status of >  or Karnofsky performance status <  (suggesting patient is capable of only limited self-care, confined to bed or chair more than % of waking hours, or requires considerable assistance and frequent medical care) as rated by the attending oncologist
SCREENING PHASE: Eastern Cooperative Oncology Group performance status -
INTERVENTION PHASE: Eastern Cooperative Oncology Group performance status -
Eastern Cooperative Oncology Group (ECOG) performance status - (at the time the subject signs their first informed consent form);
Easter Cooperative Oncology Group (ECOG) performance status  or 
Eastern Cooperative Oncology Group (ECOG) ranging from  (asymptomatic) to  (symptomatic and in bed > % of the day)
Eastern Cooperative Oncology Group (ECOG) performance status of - at Screening or by the day chemotherapy is initiated
Have an Eastern Cooperative Oncology Group (ECOG) Performance Status of , , or . However, potential subjects with an ECOG of  may be enrolled provided their condition does not preclude performing the actions required by study participation (e.g., opening medication bottles, swishing the oral rinse and spitting out, completing or participating in completion of daily diaries and FACT-H&N forms).
Eastern Cooperative Oncology Group (COG) performance status of -
Eastern Cooperative Oncology Group (ECOG) performance status  or  (fully active or restricted only in physically strenuous activity)
Southwestern Oncology Group (SWOG) performance status of   
The patient must have an Eastern Cooperative Oncology Group (ECOG) performance status of - or, based on judgment of the treating medical oncologist, can tolerate imaging and at least  months of ET
Eastern Cooperative Oncology Group (ECOG) or Karnofsky performance status will not be employed, but patients will need to be sufficiently healthy to tolerate all study procedures
AIM : Participants must be Eastern Cooperative Oncology Group (ECOG) status -
Has Eastern Cooperative Oncology Group (ECOG) performance status of  or , with no deterioration over the previous  weeks
Easter Cooperative Oncology Group (ECOG) performance status  or 
Non-metastatic GI cancers are eligible only if the Eastern Cooperative Oncology Group (ECOG) performance status is , , or  at the time of consent (although patients with locally advanced [stage III] and inoperable pancreatic cancers are eligible regardless of their performance status)
Women and men ? years of age with Eastern Cooperative Oncology Group (ECOG) performance status of  or 
The patient must have recovered from surgery with the incision completely healed and no signs of infection; if adjuvant chemotherapy was administered, chemotherapy-related toxicity that may interfere with delivery of radiation therapy should have resolved; the patient must have an Eastern Cooperative Oncology Group (ECOG) performance status of  or  (Karnofsky performance status [KPS] > %)